Sinocare Inc. (SHE:300298)

China flag China · Delayed Price · Currency is CNY
17.15
+0.26 (1.54%)
At close: Mar 6, 2026
-29.42%
Market Cap 9.50B
Revenue (ttm) 4.71B
Net Income (ttm) 281.95M
Shares Out 554.14M
EPS (ttm) 0.51
PE Ratio 33.55
Forward PE 22.13
Dividend 0.22 (1.28%)
Ex-Dividend Date Jun 13, 2025
Volume 3,298,700
Average Volume 6,149,503
Open 16.82
Previous Close 16.89
Day's Range 16.82 - 17.16
52-Week Range 16.36 - 25.45
Beta -0.24
RSI 40.11
Earnings Date Apr 16, 2026

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the Pe... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 5,014
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300298
Full Company Profile

Financial Performance

In 2024, Sinocare's revenue was 4.44 billion, an increase of 9.47% compared to the previous year's 4.06 billion. Earnings were 326.29 million, an increase of 14.73%.

Financial Statements

News

There is no news available yet.